QuantLogix ← LLY scorecard
📅 LLY Earnings Preview
Eli Lilly & Co.
Next report (est.)
01/13/2027
Countdown
123 days
EPS growth YoY
+26.2%
Revenue growth YoY
+47.7%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
08/05/2026 ±3.5% +4.9% under-priced
10/30/2025 ±2.3% +3.8% under-priced
08/07/2025 ±3.1% -14.1% under-priced
05/01/2025 ±2.8% -11.7% under-priced
10/30/2024 ±1.4% -6.3% under-priced
08/08/2024 ±5.2% +9.5% under-priced
04/30/2024 ±2.2% +6.0% under-priced
11/02/2023 ±2.8% +4.7% under-priced
Across these reports, options implied an average ±2.9% move vs an actual average of 7.6% — the stock stayed inside the implied band 0% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $7.94 $23.0B $7.1B
Q1 FY2026 $8.25 $19.8B $7.4B
Q4 FY2025 $7.39 $19.3B $6.6B
Q3 FY2025 $6.21 $17.6B $5.6B
Analyst posture
Buy / Strong Buy
30
Hold
7
Sell
1
Stable: +0 net change 30d
Live 5-factor engine read: Neutral · 44/100 Full scorecard →
Get alerted before every LLY report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on LLY before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Eli Lilly & Co. (LLY) reports in 123 days, with the next report estimated for 01/13/2027. Across the last 8 reports, options priced an average ±2.9% earnings move while the stock actually moved 7.6% on average — the market has tended to under-price LLY's earnings risk. Fundamentals into the print: EPS up 26.2% year-over-year, revenue up 47.7%. QuantLogix's live 5-factor engine currently reads LLY as a neutral at 44/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →